Basic Information
Basic information for LINC00343-242-25aa-2
Peptide Name LINC00343-242-25aa-2
Genome Position chr13:105731634-105731708[+]
Species Human
Peptide Sequence MDGCQAKINFLWTRPRARQEENKHV
Peptide Length 25
Unique No (LINC00343-204-25aa,LINC00343-206-25aa-1,LINC00343-209-25aa,LINC00343-210-25aa-2,LINC00343-211-25aa,LINC00343-212-25aa,LINC00343-213-25aa,LINC00343-214-25aa,LINC00343-215-25aa,LINC00343-217-25aa,LINC00343-218-25aa,LINC00343-219-25aa,LINC00343-220-25aa,LINC00343-221-25aa-2,LINC00343-223-25aa-2,LINC00343-224-25aa-2,LINC00343-226-25aa-2,LINC00343-228-25aa,LINC00343-229-25aa-2,LINC00343-231-25aa-2,LINC00343-234-25aa-2,LINC00343-235-25aa-1,LINC00343-236-25aa-2,LINC00343-238-25aa,LINC00343-245-25aa-2,LINC00343-247-25aa-1,LINC00343-251-25aa-2,LINC00343-254-25aa-2,LINC00343-259-25aa-1,LINC00343-260-25aa,LINC00343-261-25aa-1,LINC00343-266-25aa-1,LINC00343-269-25aa,LINC00343-272-25aa-2,LINC00343-274-25aa,LINC00343-276-25aa,LINC00343-278-25aa-2,LINC00343-279-25aa,LINC00343-280-25aa,LINC00343-282-25aa,LINC00343-283-25aa-1,LINC00343-285-25aa-2,LINC00343-286-25aa-2,LINC00343-287-25aa,LINC00343-295-25aa,LINC00343-300-25aa-2,LINC00343-301-25aa-2,LINC00343-304-25aa-1,LINC00343-305-25aa,LINC00343-308-25aa-2,LINC00343-311-25aa,LINC00343-313-25aa,LINC00343-316-25aa-1,LINC00343-319-25aa-2,LINC00343-322-25aa,LINC00343-327-25aa,LINC00343-329-25aa,LINC00343-331-25aa)
Grand Average of Hydropathicity -1.172
Relative Molecular Mass 3460.85
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000658169;LINC00343-242
Transcript Length 1376
Coding Ability 0.6664
DNA Sequence Corresponding to Peptide ATGGATGGCTGTCAGGCAAAAATAAATTTCCTGTGGACAAGACCAAGAGCAAGGCAAGAGGAAAATAAACATGTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :